Русский

Pharmaceutical Industry Information Portal

HomeTagsOmicron

All posts by tag

Omicron

The Omicron variant is a variant of SARS-CoV-2, the virus that causes COVID-19. As of December 2021, it is the newest variant. It was first reported to the World Health Organization (WHO) from South Africa on 24 November 2021. On 26 November 2021, the WHO designated it as a variant of concern and named it “Omicron”, the fifteenth letter in the Greek alphabet

World Pharma News

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Techno -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta vaccine candidate. Sanofi-GSK’s vaccine is...
World Pharma News

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

Techno -
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...
Discovery and Development

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

Techno -
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...
Manufacturers News

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Techno -
Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate...
World Pharma News

WHO: COVID-19 vaccines in the context of the circulation of the Omicron

Techno -
The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to review and assess the public...
Regulatory News

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

Techno -
The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...
12Page 1 of 2
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories